KREMPA DAVID (Chief Business Officer) reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/14/2026ACC: 0001437749-26-001288
Officer· Chief Business Officer
Since Mar 2023
+64.57K
Net shares
Net buyer
$30.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
66.51K acquired · 1.94K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.94K
Price / share
$15.62
Trade value
$30.33K
% of position
0.3%
1/14/2026
632.18K→630.24K
Total
Net shares
−1.94K
Net value
-$30.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | F · Tax Withholding | −1.94K | $15.62 | $30.33K | 0.3% | 632.18K | 630.24K |
| Total | −1.94K | -$30.33K | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
40.66K shares
Shares
+40.66K
Strike price
15.47
Held after
670.89K
Exercisable
—
1/12/2026
Restricted Stock Units
Direct
Converts to
Common Stock
25.86K shares
Shares
+25.86K
Strike price
Held after
696.75K
Exercisable
—
1/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock40.66K shares | 1/12/2026 | A · Award | +40.66K | 15.47 | — | 670.89K |
| Restricted Stock Units Direct | Common Stock25.86K shares | 1/12/2026 | A · Award | +25.86K | — | 696.75K |